Page last checked 2026-08-12

Where you are

Finding GLP-1 care near you

Start by comparing the care, not just the distance. Check whether the visit is in person or online, who provides it, what the clinic charges and whether new-patient appointments are actually available. A GLP-1 still requires a prescription in every state.

Source: 8 things people mean by the question, sorted by whether the answer moves — checked 2026-08-12

What matters first

Changes by location: 3 things
Stays national: 5 things
Prescription: Required in every state
Miami pilot: 2 clinic listing previews
Lowest published cash row: $149 for Tablet, 1.5 mg

We are building the clinic network carefully, one sourced profile at a time. The first two Miami listings are available below as previews. They are not rankings, and we do not hide missing prices or appointment information.

Compare peptide therapy clinics in Miami

Miami clinic listings

Compare our first two Miami clinic listings

These are clinic listings, not rankings or recommendations. Each listing brings the clinic’s published price, address, care team, license record and booking link into one place. It also says clearly what we could not confirm.

Clinic listing

Covalent Health Wellness & Aesthetics

Miami, FL · in person + telehealth

Visit: New-patient weight-loss visit
Price: $150 displayed
Availability: Peptide appointment dates not confirmed

View clinic details

Clinic listing

SkinLocal Midtown

Miami, FL · in person

Visit: New-patient peptide consultation
Price: $200 displayed
Availability: Appointment dates not confirmed

View clinic details

Own or represent one of these clinics? You can correct or remove a listing. Every request is reviewed before public details change.

The 3 things that actually change

These are the details that can change from one clinic, pharmacy or insurance plan to the next. Our pilot profiles show them only when a dated public source supports the answer.

Whether a counter has your strength today
Changes with where you are
A pen comes in fixed strengths, and a shop either has yours in the drawer or does not. That changes by the day and by the branch.
Who holds it: Nobody publishes it. We do not hold it, and the map panel does not either.
What your state allows at a distance
Changes with where you are
Telehealth and pharmacy practice are set state by state, and the rules move.
Who holds it: Each state’s own boards. We have not read and dated all fifty, so this page names none of them.
What your plan covers
Changes with where you are
Plans are sold state by state and employer by employer. Two people in one town can get different answers.
Who holds it: Your plan’s own formulary, which is the only document that settles it.

The medicine itself does not change by ZIP code. The practical differences are the clinic, its fees, your coverage and whether the pharmacy has the prescribed product in stock.

Everything else is the same everywhere

These 5 are settled by a federal file or by a manufacturer’s own published terms. One answer, one date, and the same for a reader in any state.

What you are asking	The answer, wherever you are	Who publishes it
Whether you need a prescription	Federal law makes every drug on this site prescription-only. No counter in any state can lawfully sell one without it.	One federal statute, which reads the same in every state.
Whether the drug is in shortage	FDA keeps one shortage list for the whole country. A drug is on it or it is not, and the answer does not change by state.	FDA’s own shortage database, read fresh and dated on every page that shows it.
What the maker charges for cash	Both manufacturers publish one cash price list, and it applies wherever you live. The advertised figure is usually a starting strength rather than a monthly rate.	Each manufacturer’s own program terms, with the date they were read.
What a pharmacy paid for the box	CMS surveys pharmacies across the country and publishes one national average every week. Nobody is charged it, and it is the only public number under the counter.	The CMS acquisition-cost file, republished weekly.
Which companies FDA has written to	FDA’s warning letters are federal and public. A letter is a fact about a company, not about a place.	FDA’s published warning-letter record.

The shortage list is the clearest case

A shortage is a fact about the country, not about a street. FDA runs one database, and a drug is either in it or it is not. Driving further does not change the entry, and neither does asking a different pharmacy.

Neither semaglutide nor tirzepatide is on FDA’s shortage list today, checked 14 August 2026.

Status comes from FDA’s drug shortage database on the date shown. The list changes daily. openFDA, read 2026-08-14.

So is the price the maker publishes

NovoCare Pharmacy self-pay — the published cash row

$149 for Tablet, 1.5 mg. Starting strength. The label moves off it after 30 days.

A month here means 28 days and one box of four pens for the shot, or 30 days and one bottle of 30 tablets. That figure is the same for a reader in any state, and the terms were read 2026-08-12.

What a clinic charges on top of it is a different number, set by that clinic, and nobody publishes those in one place. Every published ladder, with the maker’s own conditions, is at the cost record.

What you are really asking a counter

The searches that sit beside this one are about the counter rather than the distance: can a drug store sell it, can a chain, can anyone sell it without a prescription. Those have the same answer in every town.

A pharmacy fills a prescription. It does not write one, and it cannot lawfully sell a GLP-1 to somebody who has none. So the shop nearest you is rarely the step that is missing. The missing step is usually the clinician, and that step now happens by video as often as in a room.

Mail changes the geography completely. A manufacturer’s own pharmacy and most telehealth services ship from one place to every state, which is why a national price list exists at all. All seven routes, and who each one shuts out, are on the access record. The companies FDA has written to about selling these drugs are listed at the enforcement record.

Questions people actually ask

Can you get a GLP-1 over the counter?

No, and not in any state. Federal law makes these drugs prescription-only, so a shop that offers one without a prescription is not selling an approved medicine. That is what most of FDA’s letters to internet sellers are about.

Can I get one at a chain pharmacy?

A pharmacy fills a prescription somebody else wrote. Whether that branch has your strength on the day is the genuinely local part of the question, and nobody publishes a live stock list — not us, and not the map panel.

Is it cheaper somewhere else?

The maker’s cash price is one national list, so that part does not move. What moves is your plan and whatever a clinic charges for its own service, and the second of those is not published anywhere in one place.

Is the drug in shortage where I live?

Neither semaglutide nor tirzepatide is on FDA’s shortage list today, checked 14 August 2026.

Can I compare clinics here?

It links to two Miami listing previews while we test the Access Network. They are not paid rankings or recommendations. Each profile shows the facts we checked and the details that remain unconfirmed.

2Scope and reviewWhat this location record cannot cover, and how it is checked

What can change near you

The Miami pilot is not complete local coverage. It cannot tell you whether every nearby clinic is open, has stock or is accepting patients.
No state’s telehealth or pharmacy rule is stated here. Naming one would mean reading and dating fifty of them, and we have not done that work.
This is a description of routes that exist and prices that are published. It is not advice about which one to take, and it is not medical or legal advice.
Only a licensed clinician can write a prescription. Nothing here helps anyone get a prescription.
Prices move. Every figure on the cost pages carries the date its source was read, and manufacturer terms change without notice.
Insurance is not covered in any depth, because plans differ so much that a general statement about coverage would be wrong for most readers.
State law is not covered. Pharmacy practice and telehealth rules are set state by state and they differ.

How we checked these details

Medically reviewed by Jennifer Montecillo, MD · non-practicing medical reviewer

Reviewed 2026-08-12

No seller is named as a place to buy, ranked or linked here, and no listing on this site is for sale. Each row above says who publishes it or, where nobody does, that nobody does. The wider rules are in the sourcing methodology; corrections go to contact@healthspanledger.com.

The same question for semaglutide — what the local results are actually selling under that word, and which of them has a published price.
Every route to a GLP-1 — the seven that exist, what each publishes about cost, and who each one shuts out.
What each product costs — every published ladder, with the maker’s own exclusions quoted.
The compounding record — the shortage determinations and the dates each compounding window closed.

Sources

21 U.S.C. § 353(b) — the provision that makes these drugs prescription-only · United States Code, 2023 Edition — via GovInfo · retrieved 2026-08-12
FDA warning letters — the published enforcement record, searchable by company and by text · U.S. Food and Drug Administration · retrieved 2026-08-12
BeSafeRx — FDA’s guidance on buying medicine from a website · U.S. Food and Drug Administration · retrieved 2026-08-12
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of 06/15/2026) · U.S. Food and Drug Administration · retrieved 2026-08-12
FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (content current as of 04/01/2026) · U.S. Food and Drug Administration · retrieved 2026-08-12
FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List (news release, April 30, 2026) · U.S. Food and Drug Administration · retrieved 2026-08-12

Where this leads next

Start here if peptides are new to you

One page that leads to compounds, goals, calculators, costs and care access.

Glutathione IVs, injections and supplements compared

See why evidence for one form does not prove the others work.

Does an L-carnitine shot cause weight loss?

The label answer and the separate FDA warning about fat-dissolving injections.

The retatrutide letters, and what they allege

There is no lawful way to buy retatrutide in the United States.

Do B12 shots help with weight loss?

What the current U.S. label covers and what it does not.

The coverage question, in the order it is decided

6 federal definitions, and the one document to open at each gate.